Class III β-tubulin (βIII) in particular has been observed to be overexpressed in many forms of cancer, particularly drug-resistant cancer [6], whereas βI is constitutively expressed, and βII is highly expressed in brain tissue [21]. This evidence concerns the gene CACNA1E and cancer.